MethylprednisoloneLack of efficacy and off-label use in unapproved indication: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2021卷 / 1期

关键词：

D O I：

10.1007/s40278-024-65098-y

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：303 / 303

相关论文

共 50 条

[21] Avatrombopag/eltrombopagGastrointestinal disorder, tremor and off-label use in unapproved indication: 3 case reports
[J]. Reactions Weekly, 2023, 1986 (1) : 80 - 80
[22] BaricitinibDrug ineffective in unapproved condition following off-label use: case report
[J]. Reactions Weekly, 2023, 1938 (1) : 306 - 306
[23] Antituberculars/remdesivir/methylprednisoloneLack of efficacy and off label use: case report
[J]. Reactions Weekly, 2023, 1942 (1) : 56 - 56
[24] Multiple drugsRhino orbital mucormycosis due to off label use in unapproved indication and lack of efficacy: case report
[J]. Reactions Weekly, 2022, 1936 (1) : 358 - 358
[25] AntineoplasticsLack of efficacy and off-label use: case report
[J]. Reactions Weekly, 2021, 1866 (1) : 47 - 47
[26] AntineoplasticsLack of efficacy and off-label use: case report
[J]. Reactions Weekly, 2023, 1943 (1) : 84 - 84
[27] AzithromycinLack of efficacy and off-label use: case report
[J]. Reactions Weekly, 2021, 1878 (1) : 110 - 110
[28] HydroxychloroquineLack of efficacy and off-label use: case report
[J]. Reactions Weekly, 2022, 1925 (1) : 264 - 264
[29] DexamethasoneLack of efficacy and off-label use: case report
[J]. Reactions Weekly, 2022, 1910 (1) : 178 - 178
[30] AcetylcysteineLack of efficacy and off-label use: case report
[J]. Reactions Weekly, 2022, 1900 (1) : 16 - 16

← 1 2 3 4 5 →